CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
177Lu PSMA 617 is a new type of therapy which is designed to deliver high doses of radiation directly to prostate cancer sites in t ...
Phase 2
Montreal, Quebec, Canada and 9 other locations
Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, pros...
Montréal, Quebec, Canada and 38 other locations
subjects presenting not previously treated for castration resistant prostate cancer and showing negative or equivocal findings per ...
Phase 2
Montréal, Quebec, Canada and 3 other locations
androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...
Phase 3
Montréal, Quebec, Canada and 92 other locations
The purpose of this study is to investigate potential drug-drug interaction (DDI) between JNJ-56021927 and abiraterone acetate and between JNJ-560219...
Phase 1
Montreal, Quebec, Canada and 6 other locations
ACCEL is a multicenter, open label phase Ia/Ib/II study of \[Ac-225\]-PSMA-62 in participants with prostate-specific membrane antigen (PSMA) ...
Phase 1
Montreal, Quebec, Canada and 6 other locations
The purpose of this study is to find out what effects a new drug, palbociclib, has on prostate cancer and will look at the side eff...
Phase 2
Montreal, Quebec, Canada and 6 other locations
with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials....
Phase 4
Montreal, Quebec, Canada and 53 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Montreal, Quebec, Canada and 131 other locations
approach.Participants with high-risk prostate cancer planned for curative-intent standard-of-care radiotherapy or surgery, or with...
Phase 3
Montreal, Quebec, Canada and 18 other locations
Clinical trials
Research sites
Resources
Legal